Testing effectiveness (Phase 2)Ended earlyNCT00040144
What this trial is testing
Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 85